Cardiac Insufficiency Clinical Trial
Official title:
Cardiac Resynchronization Therapy: Relevance of the Surgical Approach in the Implantation of the Left Ventricular Probe
Heart failure is very common and reaches more than 56 million people worldwide. 17 to 45
percent die in the first year of hospitalization. The most affected populations live in
Western countries like Europe or the USA.
It is defined by a set of signs and symptoms such as dyspnea, asthenia, edema or tachycardia
but must be objectified, preferably by ultrasound. Its basic treatment is based on a
lifestyle improvement and a reduction of the risk factors (hypertension, dyslipidemia,
diabetes, ...), as well as an optimal medical treatment based on ACE inhibitors, B-blockers,
ARA2 (Sartans), spironolactone or digoxin.
When the optimal treatment is no longer working and that the cardiac desynchronization is
demonstrated, be it atrio-ventricular, inter-ventricular or intra-ventricular, the patient
can benefit from a three-probes cardiac resynchronization to resynchronize the two
ventricles. The classic approach, performed by a cardiologist, is to perform an endovenous
procedure in order to place the 3 probes under local anesthesia.The first one goes in the
right atrium, the second one in the right ventricle and the third one goes in the left
ventricle. It is the placement of this third one that often causes trouble. It is more
difficult to place since it must pass through the coronary sinus, outside of the heart,
unlike the first two probes that are placed endocavitary. When the practitioner fails to
place the probe correctly or obtains inappropriate levels of detection, stimulation, or
impedance thresholds, a cardiac surgeon must intervene and carry out a mini-thoracotomy.
The CHU Brugmann Hospital is in favor of a mixed surgical approach. The probes are placed by
a cardiac surgeon, who first starts by a endo-venous placement under local anesthesia. If
that approach fails, the local anesthesia can be transformed into general anesthesia at the
same operative time and a mini-thoracotomy is performed.
The aim of this study is to evaluate the immediate impact of this surgical management within
the CHU Brugmann hospital, in patients suffering from cardiac insufficiency despite proper
medication.The hypothesis is that the mixed surgical approach improves the prognosis of
cardiac resynchronization.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03306017 -
Effects of Left Ventricular Assist Device Implantation on the Phenotype of Blood Platelets and Leucocytes
|
N/A | |
Recruiting |
NCT03648736 -
Time Course of Circulating Myocardial Biomarkers After a TASH Procedure.
|
||
Recruiting |
NCT02862197 -
Invasive Monitoring of Pulmonary Artery Pressure (PAP) Among Dialysis Treated Patients
|
N/A | |
Recruiting |
NCT03882580 -
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
|
||
Recruiting |
NCT03673631 -
Oxygenation Methods and Non-invasive Ventilation in Patients With Acute Respiratory Failure and a do Not Intubate Order
|
||
Recruiting |
NCT05255952 -
Epicardial Stimulation of the Cardiac Autonomic Nervous System
|
N/A | |
Not yet recruiting |
NCT03428308 -
Detection and Treatment of Somatic Disease in Patients With Severe Mental Disease
|
N/A |